Physician profile
Peter Hyans
NPI 1528060605
$1,066.17
in general payments reported to CMS, 2019-2025
10 companies · $483 in 2025
The $483 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.31 · 2020: $57.69 · 2021: $151 · 2022: $84.24 · 2023: $193 · 2024: $73.44 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $749.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $523.45 | 2023-2025 | |
| Mentor Worldwide LLC | $302.47 | 2021-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Seagen INC. | $60.00 | 2021 | |
| Revance Therapeutics, INC. | $48.44 | 2024-2025 | Daxxify |
| Allergan, INC. | $40.34 | 2020-2022 | |
| Tepha INC | $35.98 | 2020 | |
| Lilly USA, LLC | $23.31 | 2019 | |
| Medline Industries LP | $16.66 | 2023 | |
| Ethicon US, LLC | $15.52 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Hyans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.